Literature DB >> 18633332

Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.

Zhengsheng Zou1, Baosen Li, Dongping Xu, Zheng Zhang, Jing-Min Zhao, Guangde Zhou, Yanling Sun, Lei Huang, Junliang Fu, Yongping Yang, Lei Jin, Wei Zhang, Jun Zhao, Ying Sun, Shaojie Xin, Fu-Sheng Wang.   

Abstract

GOALS: This study attempts to determine expressions of intrahepatic proinflammatory and anti-inflammatory cytokines and their secreting immunocytes to evaluate their roles in the pathogenesis of acute-on-chronic liver failure (ACLF) in chronically hepatitis B virus (HBV)-infected patients.
BACKGROUND: ACLF generally affects patients with established, compensated chronic liver diseases who develop an acute deterioration in liver function. In China, HBV-associated ACLF patients account for more than 80% of ACLF patients owing to a high prevalence of chronic HBV infection. Clinical observation showed that the deterioration of this disease may correlate with host immune responses, but related underlying mechanism remains largely unknown. STUDY: In situ expressions of interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin-10 (IL-10), and their secreting CD4, CD8 T cells, and Kupffer cells (KCs) were analyzed in the livers of patients with ACLF, chronic hepatitis B (CHB), and normal controls (NC) using immunohistochemistry.
RESULTS: Intrahepatic proinflammatory IFN-gamma and TNF-alpha expressions were markedly up-regulated in ACLF compared with CHB and NC. However, similar anti-inflammatory IL-10 expressions were observed in ACLF and CHB. IFN-gamma overexpression correlated significantly with increased CD4 and CD8 T-cell accumulation. TNF-alpha up-regulation also correlated significantly with increased KCs.
CONCLUSIONS: The imbalanced expression of proinflammatory and anti-inflammatory cytokines and increased accumulation of CD4, CD8 T cells, and KCs may contribute to immunopathogenesis in HBV-infected ACLF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18633332     DOI: 10.1097/MCG.0b013e3181624464

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  38 in total

Review 1.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

2.  High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation.

Authors:  Bing-Yi Lin; Lin Zhou; Lei Geng; Zhi-Yun Zheng; Jun-Jun Jia; Jing Zhang; Jia Yao; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

Review 3.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  The role of neutrophils in the development of liver diseases.

Authors:  Ruonan Xu; Huihuang Huang; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2014-03-17       Impact factor: 11.530

5.  Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage.

Authors:  Biplob Kumar Saha; Mamun Al Mahtab; Sheikh Mohammad Fazle Akbar; Sheikh Mohammad Noor-E-Alam; Ayub Al Mamun; Sharker Mohammad Shahadat Hossain; Mohammad Ashraful Alam; Ahmed Lutful Moben; Faiz Ahmad Khondaker; Forhadul Islam Chowdhury; Ruksana Raihan; Salimur Rahman; Ashok Kumar Choudhury
Journal:  Hepatol Int       Date:  2017-08-24       Impact factor: 6.047

6.  Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy.

Authors:  Juan Zhao; Ji-Yuan Zhang; Hong-Wei Yu; Yu-Lan He; Jing-Jing Zhao; Juan Li; Yue-Ke Zhu; Qin-Wei Yao; Jin-Huan Wang; Hai-Xia Liu; Shu-Yun Shi; Zheng-Sheng Zou; Xiang-Sheng Xu; Chun-Bao Zhou; Fu-Sheng Wang; Qing-Hua Meng
Journal:  Cell Mol Immunol       Date:  2012-01-09       Impact factor: 11.530

7.  Enhanced peripheral γδT cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression.

Authors:  Min Chen; Peng Hu; Hui Peng; Weiqun Zeng; Xiaofeng Shi; Yu Lei; Huaidong Hu; Dazhi Zhang; Hong Ren
Journal:  J Clin Immunol       Date:  2012-03-14       Impact factor: 8.317

Review 8.  Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure.

Authors:  En-Qiang Chen; Fan Zeng; Ling-Yun Zhou; Hong Tang
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Quercetin Protects Mice from ConA-Induced Hepatitis by Inhibiting HMGB1-TLR Expression and Down-Regulating the Nuclear Factor Kappa B Pathway.

Authors:  Xi Li; Hong-Chun Liu; Qun-Yan Yao; Bei-Li Xu; Shun-Cai Zhang; Chuan-Tao Tu
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

10.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.